Two-Compartment PK (IV Bolus)

ورودی‌های بالینی بیمار

حداقل ۰.۰۰۱ — حداکثر ۱۰۰۰۰۰

حداقل ۰.۰۱ — حداکثر ۲۰ • واحد: /h

حداقل ۰.۰۰۱ — حداکثر ۱۰۰۰۰۰

حداقل ۰.۰۰۱ — حداکثر ۲۰ • واحد: /h

حداقل ۱ — حداکثر ۱۶۸ • واحد: h

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
cmax ss
—concentration units
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Computed0–0
Direct Clinical Answer

The Two-Compartment PK (IV Bolus) calculates calculating standardized physiological indices and stratifying general clinical risk. Key inputs include a. Scores guide individualizing bedside clinical management, scheduling routine follow-up, and monitoring clinical progress. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Two-compartment pharmacokinetic steady-state prediction for intermittent IV bolus dosing, using macro-constants (C(t) = A×e^(−αt) + B×e^(−βt) per dose). Superposition gives Cmax_ss = A/(1−e^(−ατ)) + B/(1−e^(−βτ)) and Cmin_ss with each term decayed over the interval. A, B from a fitted bolus profile; α > β.

Clinical Indication

The Two-Compartment PK (IV Bolus) is indicated for bedside clinical practice to support Two-compartment pharmacokinetic steady-state prediction for intermittent IV bolus dosing, using macro-constants (C(t) = A×e^(−αt) + B×e^(−βt) per dose). Superposition gives Cmax_ss = A/(1−e^(−ατ)) + B/(1−e^(−βτ)) and Cmin_ss with each term decayed over the interval. A, B from a fitted bolus profile; α > β.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult ambulatory and hospitalized patient cohorts evaluated for systemic illness, physiologic risk, or diagnostic probability. Clinical application is indicated across General medical-surgical inpatient units, primary care clinics, and ambulatory outpatient facilities.

Limitations & Contraindications

Single-point score values can obscure rapid temporal clinical deterioration; serial clinical reassessment is essential.

Clinical Pearls & Action Plan

Calculated indices must be contextualized alongside complete clinical history, physical exam, and dynamic trajectory.

Formula & Variables:

Cmax_ss = A/(1-e^(-ατ)) + B/(1-e^(-βτ)); Cmin_ss = A*e^(-ατ)/(1-e^(-ατ)) + B*e^(-βτ)/(1-e^(-βτ))

Input Parameters

NameTypeRequiredDescription
afloatYesMacro-constant A
alphafloatYesDistribution rate constant alpha(/h)
bfloatYesMacro-constant B
betafloatYesTerminal rate constant beta(/h)
taufloatYesDosing interval(h)

Score Interpretation & Guidance

RangeStageDescription
0–0ComputedPK prediction

Evidence-Based References (EBM)

  • Standard two-compartment IV-bolus superposition (e.g. Shargel & Yu, Applied Biopharmaceutics & Pharmacokinetics).

Related calculators